The information contained on the following web pages is intended exclusively for Swiss residents who are physically located in Switzerland. The following information does not contain or constitute an offer to sell or a solicitation of any offer to buy securities in the United States of America ("U.S.") or in any other jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make an offer or solicitation. Users of this web site are requested to inform themselves about and to observe any such restrictions. The securities of Basilea Pharmaceutica Ltd. have not been and will not be registered under the United States securities laws and may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. Neither Basilea Pharmaceutica Ltd. nor its shareholders intend to register any portion of the securities in the United States or conduct a public offering of securities in the United States. The information contained on the following web pages may not be distributed outside of Switzerland, in particular not in the U.S.
This communication is only being distributed to and is only directed at persons who are outside the United Kingdom ("U.K.") (all such persons together being referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on the following web pages or any of their contents. Basilea Pharmaceutica Ltd. securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons and certain other persons to whom it may lawfully be communicated.
Some of the information published in this website contains forward-looking statements. Users are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Basilea Pharmaceutica Ltd. undertakes no obligation to publicly update or revise any information or opinions published in the website. Basilea Pharmaceutica Ltd. reserves the right to amend the information at any time without prior notice.
The information contained in this website may not be considered as being a substitute for economic, legal, tax or other advice and users are cautioned to base investment decisions or other decisions solely on the content of this website. An investment decision with respect to securities of Basilea Pharmaceutica Ltd. must only be made on the basis of the offering prospectus published in accordance with Swiss law. Users must consult their investment advisers or other advisers prior to making any decisions
Please confirm that you have read the complete legend and accept its terms: